SUMATRIPTAN
Test Ligands Values Explained
- Test Ligand ID - A unique identifier for the test ligand
- Ligand Name - Name of the test ligand
Test Ligand ID | 1788 |
---|---|
Ligand Name | SUMATRIPTAN |
PubMed Compound Id | 5358 |
Structure | |
Molecular Formula | C14H21N3O2S |
Molecular Weight | 295.40 |
SMILES | CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C |
Synonyms | sumatriptan 103628-46-2 Imitrex Sumatran Sumax Imigran Sumatriptanum 1H-Indole-5-methanesulfonamide, 3-[2-(dimethylamino)ethyl]-N-methyl- 3-(2-(Dimethylamino)ethyl)-N-methyl-1H-indole-5-methanesulfonamide Imigran Recovery 1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide 1-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}-N-methylmethanesulfonamide TOSYMRA 8R78F6L9VO DFN-11 3-[2-(Dimethylamino)ethyl]-N-methylindole-5-methanesulfonamide DTXSID4023628 CHEBI:10650 N02CC01 1-(3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)-N-methylmethanesulfonamide DFN-11 (SUMATRIPTAN INJECTION) DTXCID303628 3-[2-(Dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide (3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide 1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-methylmethanesulfonamide 1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methylmethanesulfonamide 1H-Indole-5-methanesulfonamide, 3-(2-(dimethylamino)ethyl)-N-methyl- 3-(2-(Dimethylamino)ethyl)-N-methylindole-5-methanesulfonamide Imigran Radis (3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)-N-methylmethanesulfonamide {3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}-N-methylmethanesulfonamide 1-(3-(2-dimethylaminoethyl)-1H-indol-5-yl)-N-methyl-methanesulfonamide 1-(3-(2-dimethylaminoethyl)-1H-indol-5-yl)-N-methylmethanesulfonamide GR43175 Succinate, Sumatriptan RefChem:56076 600-462-9 GR-43175 GR 43175 Imitrex (TN) CHEMBL128 MFCD00866222 NCGC00095838-01 Sumatriptanum [INN-Latin] GR 43175X SMR000596517 Imigran (TN) CAS-103628-46-2 BRN 6930870 UNII-8R78F6L9VO Sumatriptan (JAN/USP/INN) Sumatriptan [USP:INN:BAN] AVP825 HSDB 7742 AVP 825 AVP-825 Tosymra (nasal spray) SUMATRIPTAN [MI] SUMATRIPTAN [INN] SUMATRIPTAN [JAN] SUMATRIPTAN [HSDB] GTPL54 SUMATRIPTAN [VANDF] SCHEMBL1482 SUMATRIPTAN [MART.] BSPBio_002304 SUMATRIPTAN [USP-RS] SUMATRIPTAN [WHO-DD] MLS001195659 MLS001304742 BIDD:GT0248 SPECTRUM1505372 orb1704027 SCHEMBL29450235 Sumatriptan - Bio-X trade mark HY-B0121B SUMATRIPTAN [ORANGE BOOK] HMS2231B21 HMS3369A05 SUMATRIPTAN [USP MONOGRAPH] ALBB-038603 BCP02237 MSK11291 Tox21_111528 BDBM50005835 STL451003 1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methyl-methanesulfonamide AKOS015894924 Tox21_111528_1 CCG-230331 DB00669 NCGC00095838-02 NCGC00095838-03 NCGC00095838-04 BS164424 FD146133 SY398829 SBI-0206837.P001 CS-0009565 NS00009397 C07319 C90357 D00451 EN300-123008 AB00698285-12 AB00698285-13 AB00698285_14 AB00698285_15 628S462 F600616 L000584 Q416978 BRD-K50938287-001-01-7 BRD-K50938287-001-09-0 BRD-K50938287-036-12-0 BRD-K50938287-036-13-8 3-[2-(Dimethylamino)ethyl]-N-methy-1H-indole-5-methanesulfonamide 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulphonamide (3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide # 1-[3-[2-(Dimethylamino)ethyl]-5-indolyl]-N-methylmethanesulfonamide 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole -5-methanesulphonamide |
Created At | Jan 13, 2025 2:47 pm |
Updated At | Jan 13, 2025 2:47 pm |